Psoriasis
Conditions
Interventions
Ivarmacitinib Sulfate Group:None
Sponsors
Binzhou Medical University Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Aged 18–75 years, regardless of gender. Patients meeting the diagnostic criteria, diagnosed by our department’s physicians as having moderate-to-severe plaque psoriasis based on clinical and pathological assessment, with baseline BSA =3, PASI =3, and DLQI =6.
Exclusion criteria
Exclusion criteria: Patients who are deemed ineligible for the trial by the investigator due to other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PASI 100; | — |
Secondary
| Measure | Time frame |
|---|---|
| IL-17, IL23, IL-22, TNF-a; | — |
Countries
China
Contacts
Public Contactwangjing
The Affiliated Hospital of Binzhou Medical University
Outcome results
None listed